Dopamine Uptake Inhibitors

All categories
DBCAT000440Pharmacologic class

Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. A DrugBank category of 18 drugs. 16 of them are approved.

Also known as
Dopamine Reuptake Inhibitors · Inhibitors, Dopamine Reuptake · Inhibitors, Dopamine Uptake · Reuptake Inhibitors, Dopamine · Uptake Inhibitors, Dopamine
Drugs

What you can answer from here — as of August 09, 2019

18DrugsEach linked to its full drug card
Listed above
31Drug targetsEvery drug–target pair in the class, with bond type
Sign in
3,853Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
9Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Dopamine Uptake Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In